305 related articles for article (PubMed ID: 23217616)
21. Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity.
White EA; Kramer RE; Tan MJ; Hayes SD; Harper JW; Howley PM
J Virol; 2012 Dec; 86(24):13174-86. PubMed ID: 23015706
[TBL] [Abstract][Full Text] [Related]
22. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
23. Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.
Chakrabarti O; Krishna S
J Biosci; 2003 Apr; 28(3):337-48. PubMed ID: 12734411
[TBL] [Abstract][Full Text] [Related]
24. Novel Functions of the Human Papillomavirus E6 Oncoproteins.
Wallace NA; Galloway DA
Annu Rev Virol; 2015 Nov; 2(1):403-23. PubMed ID: 26958922
[TBL] [Abstract][Full Text] [Related]
25. Molecular Mechanisms of MmuPV1 E6 and E7 and Implications for Human Disease.
Romero-Masters JC; Lambert PF; Munger K
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298698
[TBL] [Abstract][Full Text] [Related]
26. Identification of human papillomavirus type 53 L1, E6 and E7 variants in isolates from Brazilian women.
Oliveira LH; Santos LS; Augusto EF; Neves FP
Infect Genet Evol; 2012 Jan; 12(1):71-6. PubMed ID: 22056883
[TBL] [Abstract][Full Text] [Related]
27. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
28. Genetic variability in E6 and E7 genes of human papillomavirus -16, -18, -31 and -33 from HIV-1-positive women in Italy.
Garbuglia AR; Carletti F; Minosse C; Piselli P; Zaniratti MS; Serraino D; Capobianchi MR
New Microbiol; 2007 Oct; 30(4):377-82. PubMed ID: 18080672
[TBL] [Abstract][Full Text] [Related]
29. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
30. Evidence for direct interaction between the oncogenic proteins E6 and E7 of high-risk human papillomavirus (HPV).
Lim J; Lilie H; Kalbacher H; Roos N; Frecot DI; Feige M; Conrady M; Votteler T; Cousido-Siah A; Corradini Bartoli G; Iftner T; Trave G; Simon C
J Biol Chem; 2023 Aug; 299(8):104954. PubMed ID: 37354975
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus 68 prevalence and genetic variability based on E6/E7 genes in Sichuan.
He J; Li Q; Hu C; Peng J; Ma S; Song Z; Liu Y; Cui Y; Deng J; Wei X; Ding X
Virology; 2022 Feb; 567():15-25. PubMed ID: 34942562
[TBL] [Abstract][Full Text] [Related]
32. The low-risk papillomaviruses.
Egawa N; Doorbar J
Virus Res; 2017 Mar; 231():119-127. PubMed ID: 28040475
[TBL] [Abstract][Full Text] [Related]
33. Human papillomaviruses in epigenetic regulations.
Durzynska J; Lesniewicz K; Poreba E
Mutat Res Rev Mutat Res; 2017; 772():36-50. PubMed ID: 28528689
[TBL] [Abstract][Full Text] [Related]
34. Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens.
White EA; Kramer RE; Hwang JH; Pores Fernando AT; Naetar N; Hahn WC; Roberts TM; Schaffhausen BS; Livingston DM; Howley PM
J Virol; 2015 Mar; 89(5):2857-65. PubMed ID: 25540383
[TBL] [Abstract][Full Text] [Related]
35. Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses.
White EA; Sowa ME; Tan MJ; Jeudy S; Hayes SD; Santha S; Münger K; Harper JW; Howley PM
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):E260-7. PubMed ID: 22232672
[TBL] [Abstract][Full Text] [Related]
36. Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.
Keegan H; Mc Inerney J; Pilkington L; Grønn P; Silva I; Karlsen F; Bolger N; Logan C; Furuberg L; O'Leary J; Martin C
J Virol Methods; 2009 Jan; 155(1):61-6. PubMed ID: 18955086
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.
Panayiotou T; Michael S; Zaravinos A; Demirag E; Achilleos C; Strati K
PLoS Pathog; 2020 Apr; 16(4):e1008468. PubMed ID: 32298395
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
39. Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis.
Jabbar B; Rafique S; Salo-Ahen OMH; Ali A; Munir M; Idrees M; Mirza MU; Vanmeert M; Shah SZ; Jabbar I; Rana MA
Front Immunol; 2018; 9():3000. PubMed ID: 30619353
[TBL] [Abstract][Full Text] [Related]
40. E6 and E7 variants of human papillomavirus-16 and -52 in Japan, the Philippines, and Vietnam.
Ishizaki A; Matsushita K; Hoang HT; Agdamag DM; Nguyen CH; Tran VT; Sasagawa T; Saikawa K; Lihana R; Pham HV; Bi X; Ta VT; Van Pham T; Ichimura H
J Med Virol; 2013 Jun; 85(6):1069-76. PubMed ID: 23588734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
